The Wilson and Cleary framework, first proposed in the 1990s and later revised, is one of the most influential conceptual models in outcomes research. It links biological and physiological variables through symptom status and functional health to general health perceptions and, ultimately, overall quality of life. What makes the model useful is its insistence on pathways: it does not simply ask which factors correlate with quality of life, but proposes directional chains through which disease mechanisms are translated into lived experience. Applying this revised model to Parkinson’s disease allowed the study’s authors to test, in a structured and statistically explicit way, which determinants carry the greatest weight along that chain.

Parkinson’s disease is the second most common neurodegenerative disorder worldwide, and its non-motor burden is increasingly recognized as a dominant driver of disability. Depression, anxiety, apathy, sleep disturbance, pain, fatigue, and sexual dysfunction are all more prevalent in Parkinson’s than in age-matched populations, and each has been independently associated with poorer quality of life in prior work. What has been missing, the researchers argue, is an integrated, multidimensional account that places these factors in a single explanatory architecture, rather than treating them as isolated contributors measured one at a time.

The study assembled a battery of validated instruments capturing the model’s successive levels: physiological measures and clinical characteristics of the disease, symptom scales covering both motor and non-motor domains, functional assessments, mental health measures including depressive and anxiety symptoms, and dedicated evaluation of sexual health. Quality of life was assessed with disease-specific and generic instruments, allowing the authors to examine both overall health perceptions and broader life evaluation. Statistical modeling then quantified the direct and indirect effects of each determinant, revealing how influences propagate from biological dysfunction through symptoms and function to the way patients judge their own health.

The headline finding is striking in its simplicity: mental health and sexual function emerged as determinants of quality of life comparable in importance to, and in some pathways stronger than, the classical motor measures that dominate routine neurological assessment. Depressive symptoms in particular acted as a powerful hub, both directly reducing quality of life and mediating the effects of other clinical variables. Sexual dysfunction, which affects a substantial proportion of both men and women with Parkinson’s disease, contributed significantly to poorer health perceptions even after accounting for disease severity, age, and functional status. The authors emphasize that these are not peripheral complaints but central components of the patient experience.

The pathway structure of the revised model proved illuminating. Motor severity influenced quality of life partly through its effect on symptoms and daily functioning, but also through its impact on mood, illustrating an indirect route in which physical decline erodes emotional well-being, which in turn depresses overall life evaluation. Conversely, some non-motor symptoms exerted effects that were largely mediated by mental health, suggesting that psychological state functions as a gateway through which much of the disease’s subjective burden passes. This mediation pattern has practical implications: interventions targeting depression and anxiety may ameliorate the quality-of-life consequences of a range of otherwise distinct symptoms.

Sexual health deserves particular attention in this framework. Sexual dysfunction in Parkinson’s disease arises from a convergence of mechanisms, including dopaminergic degeneration affecting autonomic and limbic circuits, medication effects, motor limitations, relationship strain, and psychological factors. The study’s finding that sexual function retains a significant association with quality of life within a multidimensional model underscores that it is an independent dimension of health, not merely a byproduct of depression or disability. Yet sexual health remains one of the least discussed topics in routine Parkinson’s care, with patients frequently reluctant to raise it and clinicians rarely asking. The authors suggest that structured assessment of sexual function should be incorporated into comprehensive care pathways.

The multidimensional approach also highlights the interdependence of domains often managed by different specialists. Sleep problems feed fatigue; fatigue erodes physical activity; inactivity worsens mood and function; and each step along the chain degrades health perceptions. By modeling these relationships simultaneously, the revised Wilson and Cleary framework provides a map of where interventions might yield the greatest downstream benefit. Treating depression, optimizing dopaminergic therapy, addressing sexual dysfunction, supporting physical function, and attending to social and role functioning are not competing priorities but complementary leverage points on a shared causal network.

For clinicians, the message is that quality of life in Parkinson’s disease is not a simple readout of motor state. Two patients with comparable disease duration and comparable Unified Parkinson’s Disease Rating Scale scores may inhabit radically different subjective worlds depending on their mood, their intimate relationships, and their ability to sustain valued activities. Routine care that measures only the visible layer of the disease risks systematically underestimating the burden carried by those whose motor symptoms are well controlled but whose emotional, sexual, and social health is not. Screening instruments for depression, anxiety, and sexual function are brief, validated, and inexpensive, making systematic implementation feasible in ordinary outpatient settings.

For researchers, the study demonstrates the value of theory-driven models in a field awash with correlational data. Rather than cataloguing associations, the revised Wilson and Cleary model imposes an ordered structure that can be tested, refined, and compared across conditions and populations. The authors note that longitudinal designs will be needed to confirm the directional pathways suggested here, and that interventions designed with the model in mind, for example psychotherapy or sexual health counseling embedded within neurological care, could provide direct tests of its practical utility. If subsequent trials confirm that improving mental and sexual health yields measurable gains in overall quality of life beyond what motor optimization achieves, the study will have helped shift the center of gravity in Parkinson’s care toward a genuinely holistic medicine, one that treats patients not as motors to be tuned but as whole people whose intimacy, mood, and dignity are inseparable from their health.

Subject of Research: Determinants of health-related quality of life in Parkinson's disease, including sexual and mental health, analyzed with the revised Wilson and Cleary model

Article Title: Sexual, mental, and multidimensional determinants of health-related quality of life in Parkinson's disease using the revised Wilson and Cleary model

Article References: Alenko, A., Sudhakar, M., Chelkeba, L., Fomenko, E., & Keygnaert, I. (2026). Sexual, mental, and multidimensional determinants of health-related quality of life in Parkinson's disease using the revised Wilson and Cleary model. Scientific Reports. https://doi.org/10.1038/s41598-026-71122-z

Image Credits: AI Generated

DOI: 10.1038/s41598-026-71122-z

Keywords: Parkinson's disease, quality of life, Wilson and Cleary model, sexual dysfunction, mental health, depression, non-motor symptoms, health-related quality of life, neurodegenerative disease, patient outcomes, Sexual, mental